Venture Capital Firm attributes
Invested in
Other attributes
Company Operating Status
Active
Brandon Capital's Medical Research Commercialisation Fund is Australia's largest life sciences investment fund. The fund invests in early stage medical research discoveries.
The network that the firm has is connected to 50 leading medical research institutes and hospitals across Australia and New Zealand. Brandon Capital's Medical Research Commercialisation Fund is interested in companies such as Aravax, auspherix, Cardiora, elastagen, fibrotech therapeutics, GI Therapies, Global Kinetics Corporations, Heart Metabolics, innavac, MecRX, and Nexvet.
Timeline
No Timeline data yet.
